AZTR insider trading
NYSE American HealthcareAzitra, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Azitra, Inc.
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically modified strain of S. epidermidis, which is in a Phase 1b/2a clinical trial for treating Netherton syndrome, a skin disease; and ATR-01, a genetically modified strain of S. epidermidis that expresses an engineered recombinant human filaggrin protein, which is in the IND-enabling phase for treating ichthyosis vulgaris, a skin disease. It has a joint development agreement with Bayer for the identification and characterization of S. epidermidis strains for topical formulations. Azitra, Inc. was incorporated in 2014 and is headquartered in Branford, Connecticut.
Company website: azitrainc.com
AZTR insider activity at a glance
FilingIQ has scored 64 insider transactions for AZTR since Jun 21, 2023. The most recent filing in our index is dated Apr 20, 2026.
Across the full history, 19 open-market purchases
and 6 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on AZTR insider trades is 60.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest AZTR Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for AZTR?
- FilingIQ tracks 64 Form 4 insider transactions for AZTR (Azitra, Inc.), covering filings from Jun 21, 2023 onwards. 6 of those were filed in the last 90 days.
- Are AZTR insiders net buyers or net sellers?
- Across the full Form 4 history for AZTR, 19 transactions (30%) were open-market purchases and 6 (9%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does AZTR insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is AZTR in?
- Azitra, Inc. (AZTR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.49M.
Methodology & sources
Every AZTR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.